Keith W. Ward
2017
In 2017, Keith W. Ward earned a total compensation of $2M as Chief Development Officer at REATA PHARMACEUTICALS, a 22% decrease compared to previous year.
Compensation breakdown
| Bonus | $180,000 |
|---|---|
| Option Awards | $1,434,480 |
| Salary | $360,000 |
| Total | $1,974,480 |
Ward received $1.4M in option awards, accounting for 73% of the total pay in 2017.
Ward also received $180K in bonus and $360K in salary.
Rankings
In 2017, Keith W. Ward's compensation ranked 5,559th out of 14,666 executives tracked by ExecPay. In other words, Ward earned more than 62.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,559 out of 14,666 | 62nd |
Division Manufacturing | 2,009 out of 5,772 | 65th |
Major group Chemicals And Allied Products | 615 out of 2,075 | 70th |
Industry group Drugs | 473 out of 1,731 | 73rd |
Industry Pharmaceutical Preparations | 370 out of 1,333 | 72nd |
Source: SEC filing on April 30, 2018.
Ward's colleagues
We found two more compensation records of executives who worked with Keith W. Ward at REATA PHARMACEUTICALS in 2017.